In the midst of the ongoing Ebola outbreak in the Democratic Republic of the Congo, and in the absence of antiviral medications for the disease, the World Health Organization (WHO) has issued updated ...

The WHO has issued its first comprehensive guidelines for managing Ebola and Marburg diseases, stressing early supportive ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World ...

This is the story of a nurse in Michigan who decided to become the person she always knew she could be after experiencing the ...

Design Therapeutics has its proprietary GeneTAC platform, which gives them a small-molecule way to target repeat-expansion ...

The next issue of Sunrise will soon be in your inbox. We encountered an issue signing you up. Please try again Interested in ...

Bad trades, poor coaching and terrible communication all conspired to undercut a championship environment. There was plenty of blame on all sides.

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World Health Organization (WHO) has released its first comprehensive guidelines for ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World ...

As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...

There are currently no approved drugs that target Bundibugyo - the species of Ebola responsible for this outbreak.

A local doctor is building a medical facility he hopes will relieve a life-threatening bed shortage at King Edward VII ...